Although IKBKB rs13278372 and serum IKBKB protein levels were not significantly associated with AMD development, the presence of the A allele of IKBKB rs13278372 correlated with a poorer response to anti-VEGF therapy, suggesting its potential as a marker for treatment outcomes. This evidence concerns the gene IKBKB and age-related macular degeneration.